Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in renal transplantation between 1990 and 2002 in Spain.

Autor: Hernández, Ángel Alonso, Moreso, Francesc, Bayés, Beatriz, Lauzurica, Ricardo, Sánz-Guajardo, Dámaso, Gómez-Huertas, Ernesto, Pereira, Porfirio, Paul, Javier, Crespo, Josep, Amenábar, Juan J., Oliver, Juan, Serón, Daniel
Předmět:
Zdroj: NDT Plus; Jun2010 Supplement 2, Vol. 3 Issue suppl_2, pii21-ii25, 1p
Abstrakt: Background. Angiotensin-converting enzyme inhibitors (ACEI) and angiotensin II type 1 receptor blockers (ARB) decrease cardiovascular mortality and slow the progression of renal disease in non-transplant patients, but their impact on kidney transplant outcome has not been well established. [ABSTRACT FROM PUBLISHER]
Databáze: Complementary Index